# LifeShare Blood Center – FDA Inspection, Sep 1, 2022

Source: https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/d89ee1ee-4836-47b8-99d9-bc306a72b0c7
Source feed: FDA_Inspections

> FDA inspection 1178705 of LifeShare Blood Center, September 01, 2022. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1178705
- Company Name: LifeShare Blood Center
- Inspection Date: 2022-09-01
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1248367 - 2024-07-12

Company: https://www.keypedia.com/companies/lifeshare-blood-center/fffcc179-daf3-48cf-8a9e-0423632a6827

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
